Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided In US Food And Drug Administration Drug Labels: An Update

Abstract

A289cantly higher for dual eligible members, with full benefit duals being more adherent (OR: 1.09-1.16) than partial duals (OR: 1.07-1.09). In addition, sub-group analyses suggested that non-duals who were low income actually had lower adherence than duals who were poor (but have more benefits due to dual status). Primary care shortage area was not a significant risk factor for MA. ConClusions: MA is significantly associated with demographic and socio-economic factors. Health plans serving a high proportion of disadvantaged members may be providing better quality of care than their MA measure results suggest. Specifically, dual members had higher adherence rates than members with similar characteristics who did not receive Medicaid benefits.